SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-18-017755
Filing Date
2018-07-27
Accepted
2018-07-27 16:15:43
Documents
5
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A apvo-10ka_20171231.htm 10-K/A 402431
2 EX-31.1 apvo-ex311_9.htm EX-31.1 19734
3 EX-31.2 apvo-ex312_8.htm EX-31.2 19567
4 EX-32.1 apvo-ex321_6.htm EX-32.1 10441
5 EX-32.2 apvo-ex322_7.htm EX-32.2 10416
  Complete submission text file 0001564590-18-017755.txt   463600
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37746 | Film No.: 18974991
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1